UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 407

Sortiert nach

EBV-miR-BART7-3p promotes the EMT and metastasis of nasopharyngeal carcinoma cells by suppressing the tumor suppressor PTEN

Oncogene, 2015-04, Vol.34 (17), p.2156-2166

2015

Volltextzugriff (PDF)

Immunoscore and Immunoprofiling in cancer: an update from the melanoma and immunotherapy bridge 2015

Journal of translational medicine, 2016-09, Vol.14 (1), p.273-273, Article 273

2016

Volltextzugriff (PDF)

CXCR3/CCR5 pathways in metastatic melanoma patients treated with adoptive therapy and interleukin-2

British journal of cancer, 2013-10, Vol.109 (9), p.2412-2423

2013

Volltextzugriff (PDF)

Consistent Cytotoxic-T-Lymphocyte Targeting of Immunodominant Regions in Human Immunodeficiency Virus across Multiple Ethnicities

Journal of Virology, 2004-03, Vol.78 (5), p.2187-2200

2004

Volltextzugriff (PDF)

Targeting proapoptotic protein BAD inhibits survival and self-renewal of cancer stem cells

Cell death and differentiation, 2014-12, Vol.21 (12), p.1936-1949

2014

Volltextzugriff (PDF)

IRF-1 responsiveness to IFN-γ predicts different cancer immune phenotypes

British journal of cancer, 2013-07, Vol.109 (1), p.76-82

2013

Volltextzugriff (PDF)

Cancer Immunotherapy With Peptide-Based Vaccines: What Have We Achieved? Where Are We Going?

JNCI : Journal of the National Cancer Institute, 2002-06, Vol.94 (11), p.805-818

2002

Volltextzugriff (PDF)

High-fidelity mRNA amplification for gene profiling

Nature biotechnology, 2000-04, Vol.18 (4), p.457-459

2000

Volltextzugriff (PDF)

Advantages of mRNA Amplification for Microarray Analysis

BioTechniques, 2002-10, Vol.33 (4), p.906-914

2002

Volltextzugriff (PDF)

Inherited polymorphisms in the RNA-mediated interference machinery affect microRNA expression and lung cancer survival

British journal of cancer, 2010-12, Vol.103 (12), p.1870-1874

2010

Volltextzugriff (PDF)

Epstein-Barr virus microRNAs and lung cancer

British journal of cancer, 2011-07, Vol.105 (2), p.320-326

2011

Volltextzugriff (PDF)

Loss of Functional Beta2-Microglobulin in Metastatic Melanomas From Five Patients Receiving Immunotherapy

JNCI : Journal of the National Cancer Institute, 1996-01, Vol.88 (2), p.100-108

1996

Volltextzugriff (PDF)

Interleukin-10 and the immune response against cancer: a counterpoint

Journal of leukocyte biology, 2005-11, Vol.78 (5), p.1043-1051

2005

Volltextzugriff (PDF)

Immunizing patients with metastatic melanoma using recombinant adenoviruses encoding MART-1 or gp100 melanoma antigens

JNCI : Journal of the National Cancer Institute, 1998-12, Vol.90 (24), p.1894-1900

1998

Volltextzugriff (PDF)

Prospective Randomized Trial of the Treatment of Patients With Metastatic Melanoma Using Chemotherapy With Cisplatin, Dacarbazine, and Tamoxifen Alone or in Combination With Interleukin-2 and Interferon Alfa-2b

Journal of clinical oncology, 1999-03, Vol.17 (3), p.968-975

1999

Volltextzugriff (PDF)

IL-10 stimulatory effects on human NK cells explored by gene profile analysis

Genes and immunity, 2004-12, Vol.5 (8), p.621-630

2004

Volltextzugriff (PDF)

Phase 1 study in patients with metastatic melanoma of immunization with dendritic cells presenting epitopes derived from the melanoma-associated antigens MART-1 and gp100

Journal of immunotherapy, 2000-07, Vol.23 (4), p.487-498

2000

Volltextzugriff (PDF)

The dual role of IL-10

Trends in immunology, 2003, Vol.24 (1), p.36-43

2003

Volltextzugriff (PDF)

Immunization against epitopes in the human melanoma antigen gp100 following patient immunization with synthetic peptides

Cancer research (Chicago, Ill.), 1996-10, Vol.56 (20), p.4749-4757

1996

Volltextzugriff (PDF)

Real-Time Quantitative Polymerase Chain Reaction Assessment of Immune Reactivity in Melanoma Patients After Tumor Peptide Vaccination

JNCI : Journal of the National Cancer Institute, 2000-08, Vol.92 (16), p.1336-1344

2000

Volltextzugriff (PDF)

Intensity of the Vaccine-Elicited Immune Response Determines Tumor Clearance

The Journal of immunology (1950), 2002-01, Vol.168 (1), p.338-347

2002

Volltextzugriff (PDF)

Cell-mediated immunological responses in cervical and vaginal cancer patients immunized with a lipidated epitope of human papillomavirus type 16 E7

Clinical cancer research, 1998-09, Vol.4 (9), p.2103

1998

Volltextzugriff (PDF)

Sequential 5-Aza-2 deoxycytidine-depsipeptide FR901228 treatment induces apoptosis preferentially in cancer cells and facilitates their recognition by cytolytic T lymphocytes specific for NY-ESO-1

Journal of immunotherapy, 2001-03, Vol.24 (2), p.151-161

2001

Volltextzugriff (PDF)

Status of Activation of Circulating Vaccine-Elicited CD8+ T Cells

The Journal of immunology (1950), 2000-08, Vol.165 (4), p.2287-2296

2000

Volltextzugriff (PDF)

Short-Term Kinetics of Tumor Antigen Expression in Response to Vaccination

The Journal of immunology (1950), 2001-08, Vol.167 (3), p.1809-1820

2001

Volltextzugriff (PDF)

1 – 25 von 407

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(380)
Mit Volltextzugriff
(343)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

EBV-miR-BART7-3p promotes the EMT and metastasis of nasopharyngeal carcinoma cells by suppressing the tumor suppressor PTEN

Immunoscore and Immunoprofiling in cancer: an update from the melanoma and immunotherapy bridge 2015

CXCR3/CCR5 pathways in metastatic melanoma patients treated with adoptive therapy and interleukin-2

Consistent Cytotoxic-T-Lymphocyte Targeting of Immunodominant Regions in Human Immunodeficiency Virus across Multiple Ethnicities

Targeting proapoptotic protein BAD inhibits survival and self-renewal of cancer stem cells

IRF-1 responsiveness to IFN-γ predicts different cancer immune phenotypes

Cancer Immunotherapy With Peptide-Based Vaccines: What Have We Achieved? Where Are We Going?

High-fidelity mRNA amplification for gene profiling

Advantages of mRNA Amplification for Microarray Analysis

Inherited polymorphisms in the RNA-mediated interference machinery affect microRNA expression and lung cancer survival

Epstein-Barr virus microRNAs and lung cancer

Loss of Functional Beta2-Microglobulin in Metastatic Melanomas From Five Patients Receiving Immunotherapy

Interleukin-10 and the immune response against cancer: a counterpoint

Immunizing patients with metastatic melanoma using recombinant adenoviruses encoding MART-1 or gp100 melanoma antigens

Prospective Randomized Trial of the Treatment of Patients With Metastatic Melanoma Using Chemotherapy With Cisplatin, Dacarbazine, and Tamoxifen Alone or in Combination With Interleukin-2 and Interferon Alfa-2b

IL-10 stimulatory effects on human NK cells explored by gene profile analysis

Phase 1 study in patients with metastatic melanoma of immunization with dendritic cells presenting epitopes derived from the melanoma-associated antigens MART-1 and gp100

The dual role of IL-10

Immunization against epitopes in the human melanoma antigen gp100 following patient immunization with synthetic peptides

Real-Time Quantitative Polymerase Chain Reaction Assessment of Immune Reactivity in Melanoma Patients After Tumor Peptide Vaccination

Intensity of the Vaccine-Elicited Immune Response Determines Tumor Clearance

Cell-mediated immunological responses in cervical and vaginal cancer patients immunized with a lipidated epitope of human papillomavirus type 16 E7

Sequential 5-Aza-2 deoxycytidine-depsipeptide FR901228 treatment induces apoptosis preferentially in cancer cells and facilitates their recognition by cytolytic T lymphocytes specific for NY-ESO-1

Status of Activation of Circulating Vaccine-Elicited CD8+ T Cells

Short-Term Kinetics of Tumor Antigen Expression in Response to Vaccination

Suchergebnisse filtern